Selkirk Pharma, Inc. Expands Campus in Spokane, WA

Spokane, WA – November 1, 2021 – Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer, has executed a purchase and sale agreement to acquire 10.7 acres of land adjacent to their facility in Spokane, WA.

 

“Spokane is a special place to live, work, and invest,” said Patrick Haffey, Selkirk’s Chief Executive Officer. “We are grateful to be here and plan to make a series of long-term investments in this community over the coming years.”

The land acquisition expands the Selkirk campus to more than 27 acres, providing space for three standalone factories. Selkirk’s Plant 1, a state-of-the-art, 145,000 square foot facility located at 9110 W. Granite Ave, is under construction and will be complete in March of 2022.

Selkirk and its partners have so far invested over $90 million and will announce additional investments to build out the remaining campus at a later date. All three Selkirk factories will incorporate industry-leading technology, including isolator-based filling systems and electronic batch records.

Selkirk has 35 employees and is actively recruiting to support the start of Plant 1 operations in mid-2022. At full capacity, the Selkirk campus is expected to employ roughly 750 scientists, engineers, and operations personnel.